Novo Nordisk A/S earned $3.62 per diluted share in fiscal year 2025. This represents an increase of 15.2% from the prior fiscal year. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters Novo Nordisk A/S has filed alongside them.
FY2025 annual
EPS (Diluted)$3.62
YoY+15.2%
Source SEC Filings (20-F/6-K)Latest period FY2025, ended Dec 31, 2025ReportedCurrency USD
Annual figures, oldest first. Point at a bar to read its period.
NVO EPS (Diluted) by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
What was Novo Nordisk A/S's diluted earnings per share in fiscal year 2025?
Novo Nordisk A/S earned $3.62 per diluted share in fiscal year 2025.
How fast is Novo Nordisk A/S's diluted earnings per share growing?
Novo Nordisk A/S (NVO) diluted earnings per share rose by 15.2% year over year, from $3.14 to $3.62 in fiscal year 2025.
How has Novo Nordisk A/S's diluted earnings per share changed over the years?
Across the 11 fiscal years this page covers, Novo Nordisk A/S (NVO) diluted earnings per share went from $1.97 in fiscal year 2015 to $3.62 in fiscal year 2025.
What does diluted earnings per share mean on a financial statement?
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Novo Nordisk A/S (NVO) reported on that line in every period on record.
